A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022
- PMID: 35426361
- PMCID: PMC9012088
- DOI: 10.2807/1560-7917.ES.2022.27.15.2200278
A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022
Abstract
We estimated interim influenza A vaccine effectiveness (VE) following a late sharp rise in cases during an influenza A(H3N2)-dominated 2021/22 season, after lifting COVID-19 restrictions. In children aged 2-6 years offered a live attenuated influenza vaccine, adjusted VE was 62.7% (95% CI: 10.9-84.4) in hospitalised and 64.2% (95% CI: 50.5-74.1) in non-hospitalised children. In non-hospitalised patients aged 7-44 years, VE was 24.8% (95% CI: 12.8-35.2); VE was non-significant in remaining age groups and hospital/non-hospital settings.
Keywords: 2021/22 influenza season; Influenza A(H3N2); Vaccine effectiveness.
Conflict of interest statement
Figures
References
-
- Voldstedlund M, Haahr M, Emborg H-D, Bang H, Krause T. Real-time surveillance of laboratory confirmed influenza based on the Danish microbiology database (MiBa). Stud Health Technol Inform. 2013;192:978. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical